222 related articles for article (PubMed ID: 30134556)
1. Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity.
Chudzian J; Szlachcic A; Zakrzewska M; Czub M; Pustula M; Holak TA; Otlewski J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134556
[TBL] [Abstract][Full Text] [Related]
2. FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs.
Poźniak M; Zarzycka W; Porębska N; Knapik A; Marczakiewicz-Perera P; Zakrzewska M; Otlewski J; Opaliński Ł
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439755
[TBL] [Abstract][Full Text] [Related]
3. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
[TBL] [Abstract][Full Text] [Related]
4. Identification of a peptide antagonist of the FGF1-FGFR1 signaling axis by phage display selection.
Lipok M; Szlachcic A; Kindela K; Czyrek A; Otlewski J
FEBS Open Bio; 2019 May; 9(5):914-924. PubMed ID: 30968602
[TBL] [Abstract][Full Text] [Related]
5. Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments.
Fagète S; Botas-Perez L; Rossito-Borlat I; Adea K; Gueneau F; Ravn U; Rousseau F; Kosco-Vilbois M; Fischer N; Hartley O
Protein Eng Des Sel; 2017 Sep; 30(9):575-582. PubMed ID: 28444391
[TBL] [Abstract][Full Text] [Related]
6. High-Affinity Internalizing Human scFv-Fc Antibody for Targeting FGFR1-Overexpressing Lung Cancer.
Sokolowska-Wedzina A; Chodaczek G; Chudzian J; Borek A; Zakrzewska M; Otlewski J
Mol Cancer Res; 2017 Aug; 15(8):1040-1050. PubMed ID: 28483948
[TBL] [Abstract][Full Text] [Related]
7. Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae.
Jørgensen ML; Friis NA; Just J; Madsen P; Petersen SV; Kristensen P
Microb Cell Fact; 2014 Jan; 13():9. PubMed ID: 24428896
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability.
Huang Z; Tan Y; Gu J; Liu Y; Song L; Niu J; Zhao L; Srinivasan L; Lin Q; Deng J; Li Y; Conklin DJ; Neubert TA; Cai L; Li X; Mohammadi M
Cell Rep; 2017 Aug; 20(7):1717-1728. PubMed ID: 28813681
[TBL] [Abstract][Full Text] [Related]
9. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector.
Zhao Q; Chan YW; Lee SS; Cheung WT
Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057
[TBL] [Abstract][Full Text] [Related]
10. Dissecting biological activities of fibroblast growth factor receptors by the coiled-coil-mediated oligomerization of FGF1.
Porebska N; Pozniak M; Krzyscik MA; Knapik A; Czyrek A; Kucinska M; Jastrzebski K; Zakrzewska M; Otlewski J; Opalinski L
Int J Biol Macromol; 2021 Jun; 180():470-483. PubMed ID: 33745974
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.
Ronca R; Benzoni P; Leali D; Urbinati C; Belleri M; Corsini M; Alessi P; Coltrini D; Calza S; Presta M; Dell'Era P
Mol Cancer Ther; 2010 Dec; 9(12):3244-53. PubMed ID: 20940322
[TBL] [Abstract][Full Text] [Related]
12. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
14. Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity.
Opaliński Ł; Sokołowska-Wędzina A; Szczepara M; Zakrzewska M; Otlewski J
Sci Rep; 2017 Aug; 7(1):7121. PubMed ID: 28769084
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells.
Motallebnezhad M; Younesi V; Aghebati-Maleki L; Nickho H; Safarzadeh E; Ahmadi M; Movassaghpour AA; Hosseini A; Yousefi M
Tumour Biol; 2016 Nov; 37(11):14841-14850. PubMed ID: 27639384
[TBL] [Abstract][Full Text] [Related]
16. Screening of synthetic phage display scFv libraries yields competitive ligands of human leptin receptor.
Molek P; Vodnik M; Strukelj B; Bratkovič T
Biochem Biophys Res Commun; 2014 Sep; 452(3):479-83. PubMed ID: 25159846
[TBL] [Abstract][Full Text] [Related]
17. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
Zarei N; Fazeli M; Mohammadi M; Nejatollahi F
Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237
[TBL] [Abstract][Full Text] [Related]
18. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
19. Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers.
Borek A; Sokolowska-Wedzina A; Chodaczek G; Otlewski J
PLoS One; 2018; 13(2):e0192194. PubMed ID: 29420662
[TBL] [Abstract][Full Text] [Related]
20. A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.
Yamaji S; Saegusa J; Ieguchi K; Fujita M; Mori S; Takada YK; Takada Y
PLoS One; 2010 Apr; 5(4):e10273. PubMed ID: 20422052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
